📦 NDC / package directory — not a drug information page
Agraphis Nutans NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Agraphis Nutans products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Key stats
36
Package NDCs
14
Products
14
Active listings
0
Discontinued
1
Labelers
8
Strengths
1
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 14 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Agraphis Nutans 6 [hp_C]/1 PELLET | 37662-3431-01 | — | On market | View → |
| Agraphis Nutans 12 [hp_C]/1 PELLET | 37662-3432-01 | — | On market | View → |
| Agraphis Nutans 30 [hp_C]/1 PELLET | 37662-3433-01 | — | On market | View → |
| Agraphis Nutans 100 [hp_C]/1 PELLET | 37662-3434-01 | — | On market | View → |
| Agraphis Nutans 200 [hp_C]/1 PELLET | 37662-3435-01 | — | On market | View → |
| Agraphis Nutans 500 [hp_C]/1 PELLET | 37662-3436-01 | — | On market | View → |
| Agraphis Nutans 1 [hp_M]/1 PELLET | 37662-3437-01 | — | On market | View → |
| Agraphis Nutans 10 [hp_M]/1 PELLET | 37662-3438-01 | — | On market | View → |
| Agraphis nutans 12 [hp_C]/1 PELLET | 63545-0782-02 | — | On market | View → |
| Agraphis nutans 12 [hp_C]/1 PELLET | 63545-0782-02 | — | On market | View → |
| Agraphis nutans 6 [hp_C]/1 PELLET | 63545-0259-03 | — | On market | View → |
| Agraphis nutans 6 [hp_C]/1 PELLET | 63545-0259-03 | — | On market | View → |
| Agraphis nutans 6 [hp_C]/1 PELLET | 63545-0259-03 | — | On market | View → |
| Agraphis nutans 12 [hp_C]/1 PELLET | 63545-0782-02 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.